The NIHR Clinical Research Network are currently looking for eligible participants for the PETRUSHKA Trial.

Study summary:
The PETRUSHKA trial is funded by the NIHR and aims to assess a web-based decision support tool (PETRUSHKA tool) which combines the best evidence with patient and clinician’s preferences, to personalise antidepressant treatment in routine practice. Participants will be randomised on a 1:1 basis to the PETRUSHKA tool or to usual care. The trial lasts for 24 weeks (primary endpoint after 8 weeks) for each participant and they will be under the care of Oxford Health NHS Trust during this time.

Who can participate in the trial?

Participants aged 18 to 74 years who have a clinical diagnosis of depression and for whom an antidepressant is indicated.

How can you get involved?

To find out more about how to get involved, complete the screening form today:

#ResearchTransformsLives #BePartofResearch #NIHR #OxPPL